A campaign pitch that’s a sitting us President vowing to slas drug prices by up to 90%, and she says it already happened just months into his second term Donald Trump has signed a sweeping executive.
About a targeting what he calls global price gorging by pharmaceutical companies, the goal to make American patients pay the same for prescription drugs as people in countries like Germany, France or Canada, where the prices are often 2 to 4 times lower, and the spotlight is firmly on the multi-billion dollar market for weight loss jobs.
So what’s in Trump plan? Why is he targeting these specific drugs? And would it actually work? Let’s break it down?
Let’s begin with what’s actually inside the sweeping executive order the headline moved most favoured nation pricing. This means the drug makers must sell prescription drugs to American patients for no more than what they sell them. Foreign countries with the lowest prices. For example, if a drug costs $200 in Canada, it cannot cost more than that in America, even if that same drug is selling for $1000 in the United States. Next, the US leader is targeting the so-called mysterious middlemen.
The ones that negotiate prices between drug makers, insurers and pharmacies.
Donald Trump:-
“To accelerate these price restrictions and reductions, my administration will also cut out the middle men. We are going to totally cut out the famous middlemen. Nobody knows who they are middlemen. They have been here in the term for 25 years. Middlemen, I don’t know who they are, but they are rich.”
President Trump wants to make drug crisis more transparent by ending middlemen, while also wanting the drugs to go straight to the consumers and the US President is not stopping there. He’s also pushing for legal imports of cheaper drugs from other countries if they proven to be safe besides, the order also gives drugmakers 30 days to bring prices down or else they could face further action. The Trump administration.
Now, let’s zoom in on one part of the market, President Trump, it’s closely watching that’s the weight loss drums. The United States is facing a health crisis, with over 40% of the population being a peace , GLP1 drugs like separk, wasn’t please GLP1 drops like Z pound, ozympic and Bogo, the dominate the market are soaring popularity. Millions of Americans flock to them in search of a weight loss solution, but they come at a steep price. Some cost him over $1000 per month, meanwhile, the same drugs can cost as little as a few 100 elsewhere in Japan, for instance, the monthly price rise For a 10 mg Z pound injection pen is just over $61. President Trump sees this as a major example of what he calls price gouzing. The US is paying far more than other countries for these life-changing drugs, the drug companies defend the higher prices allow them to carry out research and develop new drugs yet.
Donald Trump:-
“Years, former suitable drug companies have said that research research Res. Development girls who are what they are, if you know reason whatsoever, they had to be borne by America alone. “
But the question is, will this pressure force companies to flash their prices? So what does this all mean for Americans for millions of patients?
Trump’s order could mean by saving drugs becoming far more affordable, imagine paying $100 for a prescription that currently costs $1000. That’s a potential win for the American public, but experts wanted drug makers. Push back and researchers say companies could simply pull out cheaper foreign markets to maintain profits and industry groups argue that flashing prices could choke our funding for research while doing little to solve the cost crisis. What’s more if trans executive order leads to legal imports of drugs from overseas, it could open up a whole new market for affordable pharmaceuticals, but there’s a bigger issue here. These important drugs have to be deemed safe. The US Food and Drug Administration would oversee the process A task It’s anything but simple.
So in present, Trump’s drug pricing plan really worked, it’s still early and the pharmaceutical industry won’t back down without a fight. Legal challenges are already proving truant tried this in his first term and his pricing order was blocked in court. This time he’s back with the broader strategy. But will it be enough to actually lower prices?
